Dow, S&P 500, Nasdaq Futures Steady After Treasury's Bond Intervention Buoys Markets

🖥️ SGLY Enters Into Non-Binding Strategic Agreement for Potential AI Data Center Campus. Stock Soars in Pre-Market

SGLY, a Nasdaq-listed digital infrastructure and high-performance computing company, today announced that it has entered into a non-binding strategic development framework agreement (the “Framework Agreement”) with Florence Development LLC relating to an approximately 900-acre industrial site in Florence, South Carolina.

The Framework Agreement establishes a framework for the parties to evaluate and, if mutually acceptable, potentially pursue the development of a large-scale U.S. platform for AI computing, hyperscale data centers, and high-performance computing infrastructure.

Except for certain binding provisions relating to exclusivity, confidentiality, publicity, representations, expenses, term, remedies, and governing law, the Framework Agreement is non-binding and does not obligate either party to consummate any transaction.

Any definitive transaction would be subject to the completion of satisfactory due diligence, utility confirmation, financing availability, governmental and corporate approvals, and the negotiation and execution of definitive agreements.

There can be no assurance that a definitive agreement will be reached or that the contemplated project will be completed on the terms, timetable, or scale currently contemplated, or at all. GlobeNewswire reports.

🧬 Evaxion Expands And Refocuses R&D Pipeline With AI-Designed Off-The-Shelf Cancer Vaccine Program. Stock Up In Pre-Market

Evaxion, a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, expands its pipeline of cancer vaccine programs with EVX-05 against the deadly brain cancer glioblastoma.

We are collaborating with experts from Duke University School of Medicine to develop EVX-05. This program targets endogenous retrovirus (ERV)-derived antigens shared between glioblastoma patients, which AI-Immunology™ has unique capabilities in identifying. These ERV antigens constitute a novel source of highly attractive targets for off-the-shelf cancer vaccines.

With its new therapeutic concept, EVX-05 is being developed as a novel therapeutic approach for glioblastoma. Current therapies are often inadequate, meaning glioblastoma remains one of the most aggressive and deadly cancers.

“We are delighted to transform our discoveries in glioblastoma into a promising new vaccine program with EVX-05, which could hold significant therapeutic potential in an area of massive unmet medical need. We have an outstanding collaboration with Duke University and now see the huge benefits of combining their extensive disease understanding and clinical expertise with the unique target discovery capabilities of AI-Immunology™,” says Birgitte Rønø, CSO and COO of Evaxion. GlobeNewswire reports.

📰 Why Is Circle Stock Surging Thursday?

Circle Internet Group Inc. (NYSE: CRCL) stock is trading higher on Thursday, extending a 9.56% gain from the previous session as crypto-related stocks rally.

The surge comes as Bitcoin (CRYPTO: BTC) touched $70,000 on Wednesday, buoyed by declining Treasury yields and political developments surrounding U.S. digital asset regulation.

Nasdaq futures are up 0.09%, while S&P 500 futures have shed 0.01%. Benzinga reports.

🤖 Why Is Wolfspeed Stock Falling Thursday?

Wolfspeed Inc. (NYSE: WOLF) stock is trading lower in Thursday’s premarket session after the company reported mixed fourth-quarter results.

Wolfspeed reported an adjusted loss of $2.26 per share, beating the consensus estimate for a loss of $2.45. Revenue totaled $149.6 million, missing the $224.48 million Street estimate.

Adjusted gross margin improved 70 basis points sequentially to negative 19.9%. Operating cash flow was negative $54 million. Benzinga reports.

💼 Edesa Biotech Stock Sinks After Fresh Capital Raise

Edesa Biotech, Inc. (NASDAQ: EDSA) shares fell nearly 13% in Thursday premarket trading after the company priced a $25 million public stock offering.

Edesa Biotech shares fell 18.27% to $4.70 in Wednesday’s after-market session, putting the stock on traders’ radars.

The move followed the company’s Q3 earnings release, which came out four days earlier. Benzinga reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) SGLY: Singularity Future Technology Ltd.

Total gain: +4.38 (146.98%)

2) WETO: Wetour Robotics Limited

Total gain: +12.24 (58.96%)

3) HTB: HomeTrust Bancshares, Inc.

Total gain: +9.41 (19.98%)

4) IPST: IP Strategy Holdings, Inc.

Total gain: +1.51 (17.87%)

5) BULL: Webull Corporation

Total gain: +1.19 (13.77%)

The closing price of the top three market percent gainers trading near or above $3 on Aug 19.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET)
Stock Analysis reports.

1) MRNA: Moderna, Inc.

Total gain: +111.42 (176.97%)

The company announced today that their personalized mRNA-based cancer vaccine, combined with Merck’s immunotherapy medication Keytruda, met initial goals in a late-stage trial. The ongoing mRNA cancer vaccine study involves 1,137 patients with high-risk melanoma that has been surgically removed. In early results, the trial met its primary target of reducing the risk of cancer recurrence and its secondary target of reducing the risk of cancer spreading to other parts of the body. Fast Company reports.

2) ZSTK: ZeroStack Corp.

Total gain: +3.120 (169.57%)

The company today announced that it has entered into a definitive transaction pursuant to which Puple AI Inc. and Blockcat Pte. Ltd. have agreed to contribute an aggregate of US$1.0 billion of Memecore tokens to the Company in exchange for 3,500,000 ZeroStack common shares and pre-funded warrants to purchase up to 36,198,293 additional common shares (the "Warrants"), with the prefunded warrants issued at a price of US$25.19 per share. Shares issuable upon exercise of the Warrants will not be issued unless and until approved by ZeroStack's shareholders in accordance with Nasdaq Listing Rule 5635, and such shares will be subject to a lock-up of up to ten years following closing. NewsFile reports.

3) YJ: Yunji Inc.

Total gain: +2.510 (144.25%)

The stock appeared to be moving on no notable news.

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

DE
Deere

Q3 2026

Before Market Open

Estimate: 4.720
Actual: 5.100

ATAT
Atour Lifestyle Holdings

Q2 2026

Before Market Open

Estimate: 0.570

Actual: 0.600

NVZMY
Novozymes

H1 2026

After Market Close

Estimate: 0.600
Actual: 1.270

Time (ET) / Report / Period

• 8:30 AM / Philadelphia Fed Business Outlook Survey / August
• 8:30 AM / Weekly Jobless Claims / Aug. 15
• 10:00 AM / Leading Indicators / July

“Every past decline looks like an opportunity, every future decline looks like a risk.”

– Morgan Housel

Sourced in: Collaborative Fund, When Things Get Wild

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.

Copyright © TradeZero 2026. All rights reserved.